Travere Therapeutics
TVTX
#4846
Rank
A$2.20 B
Marketcap
$24.81
Share price
-9.48%
Change (1 day)
133.50%
Change (1 year)

Earnings for Travere Therapeutics (TVTX)

Earnings in 2024 (TTM): -A$0.49 Billion

According to Travere Therapeutics's latest financial reports the company's current earnings are A$0.23 Billion. , an increase over its 2023 earnings that were of -A$0.63 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Travere Therapeutics from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.54 Billion-14.78%
2023 -A$0.63 Billion28.55%
2022 -A$0.49 Billion62.83%
2021 -A$0.3 Billion-4.82%
2020 -A$0.32 Billion28.91%
2019 -A$0.25 Billion43.76%
2018 -A$0.17 Billion74.54%
2017 -A$96.6 Million1.35%
2016 -A$95.31 Million-154.6%
2015 A$0.17 B-192.83%
2014 -A$0.19 Billion235.39%
2013 -A$56.07 Million226812.81%
2012 -A$0.03 Million1.92%
2011 -A$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$30.06 Million-94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$17.16 Million-96.77%๐Ÿ‡บ๐Ÿ‡ธ USA